We previously showed that adipogenesis was inhibited by SREBP2-HMGCR signaling when hPMSCs were cultured with TAO fibroblasts [7], which we consider to be a potential therapeutic agent for TAO. This evidence concerns the gene HMGCR and thromboangiitis obliterans.